Fer-In-Sol - General Information
A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Fer-In-Sol is used to build up the blood in anemia.
Pharmacology of Fer-In-Sol
The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Fer-In-Sol has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Fer-In-Sol for patients
Patients should be advised of the potential adverse reactions associated with the use of INFeD.
Hypersensitivity to the product. All anemi as not associated with iron deficiency.
Additional information about Fer-In-Sol
Fer-In-Sol Indication: Used in preventing and treating iron-deficiency anemia.
Mechanism Of Action: Fer-In-Sol is necessary for the production of hemoglobin. Fer-In-Sol-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Drug Interactions: Not Available
Food Interactions: Not Available
Generic Name: Iron
Synonyms: Not Available
Drug Category: Iron Supplement; Antianemic Agents
Drug Type: Small Molecule; Approved
Absorption: The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
Toxicity (Overdose): Acute iron overdosage can be divided into four stages. In the first stage, which occurs up to six hours after ingestion, the principal symptoms are vomiting and diarrhea. Other symptoms include hypotension, tachycardia and CNS depression ranging from lethargy to coma. The second phase may occur at 6-24 hours after ingestion and is characterized by a temporary remission. In the third phase, gastrointestinal symptoms recur accompanied by shock, metabolic acidosis, coma, hepatic necrosis and jaundice, hypoglycemia, renal failure and pulmonary edema. The fourth phase may occur several weeks after ingestion and is characterized by gastrointestinal obstruction and liver damage. In a young child, 75 milligrams per kilogram is considered extremely dangerous. A dose of 30 milligrams per kilogram can lead to symptoms of toxicity. Estimates of a lethal dosage range from 180 milligrams per kilogram and upwards. A peak serum iron concentration of five micrograms or more per ml is associated with moderate to severe poisoning in many.
Protein Binding: Not Available
Biotransformation: Not Available
Half Life: Not Available
Dosage Forms of Fer-In-Sol: Liquid Intravenous
Tablet, extended release Oral
Tablet, coated Oral
Solution / drops Oral
Chemical IUPAC Name: iron
Chemical Formula: Fe
Iron on Wikipedia: https://en.wikipedia.org/wiki/Iron
Organisms Affected: Humans and other mammals